E-Newsletter - July 2019

Renewed NCI Investigational Agent Accountability Record Forms (DARFs)

The Office of Management and Budget (OMB) has approved the NCI Investigational Agent Accountability Record (DARF) forms. No changes have been made to the forms. The forms with the new expiration date are posted to the CTEP website https://ctep.cancer.gov/forms/.
 
•           NCI Investigational Agent Accountability Record Form for Oral Agents
•           NCI Investigational Agent Accountability Record Form
 
Replace unused saved or printed copies of expired DARF forms at your site.  Sites must transition to use of the new forms within 90 days of the expiration date of the current form (i.e., within 90 days of March 31, 2019).

If you have any questions please contact the Pharmaceutical Management Branch (PMB) at (240) 276-6575 or by e-mail PMBAfterhours@mail.nih.gov.

 

 

For other articles in this issue of the Alliance E-News newsletter, see below.

• Message From the Group Chair - Monica M. Bertagnolli, MD
• PI Perspective: Alliance Health Outcomes Committee
  Michelle Naughton, PhD and Amylou Dueck, PhD (Co-Chairs)
  Jackie Lafky, MS (Program Manager)
• Changing the Guard: Director and PI, Alliance Central Protocol Operations Program
  Gin F. Fleming, MD and Olwen Hahn, MD
• Recent Alliance Protocol Activations
• Spotlight on Alliance Trials
  Alliance A091802 - Cutaneous squamous cell carcinoma
  Alliance A041701 - Chronic myeloid leukemia
  Alliance A031704 - Advanced renal cell cancer
  Alliance A031702 - Rare genitourinary tumors
• ICAREdata | Integrating Clinical Trials and Real World Endpoints
• Adding Value to the Alliance Clinical Trial Process
  Alliance Patient Advocate Committee
• Announcements
  -- Alliance Joins with ASCO, CancerLinQ and The MITRE Corporation to Publish Initial Set of Common Cancer Data Standards and Specifications Comprising mCODE (VIDEO))
  -- Recap: Alliance and Alliance Foundation Trials at 2019 ASCO
  -- Renewed NCI Investigational Agent Accountability Record Forms (DARFs)
  -- Call for Nominations + Applications: 2019/2020 Alliance Awards + Honors
  -- Alliance Appoints New Committee Chairs
• Alliance in the News
  -- GNS Healthcare Chosen to Present Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology
  -- mCODE Improves EHR Data Standardization for Cancer Research
  -- First Patient Dosed in Phase III Study of E-Selectin Antagonist Uproleselan in AML (Alliance A041701)--ASCO 2019: CALGB 90601 (Alliance): Randomized, Double-blind, Placebo-controlled Phase III Trial Comparing Gemcitabine and Cisplatin with Bevacizumab or Placebo in Patients with Metastatic Urothelial Carcinoma
  --'Magic Mouthwash' Little Help for Radiation-Induced Mucositis (Alliance A221304)
  -- Magic mouthwash effective treatment for mouth sore pain caused by radiation therapy (Alliance A221304)
  -- Mouthwashes Show Promise in Reducing Chemo-Related Oral Mucositis Pain (Alliance A221304)
  -- Giving Drugs before Surgery Lowers the Risk of Prostate Cancer Returning (CALGB 90203)
  -- Study: Identifying colorectal cancer subtypes could improve treatment (CALGB/SWOG 80405)
  -- The Fight to Save the Bladder Turns to Genomics (Alliance A031701)